September 25, 2020 Collaboration, Action, Evolution: SARC 2020 Progress Report On October 1 we will welcome our new President & CEO Steven Young. In addition, Dr. Chappie Conrad has begun his new role as Chair of the SARC Board of … Read more
September 2, 2020 SARC ANNOUNCES THE APPOINTMENT OF NEW LEADERSHIP With the decision of Denise Reinke earlier this year to step down from her roles as president and CEO and board chair, SARC is pleased to announce the successful recruitment … Read more
April 28, 2020 Message from SARC President and CEO, Denise Reinke This year will mark a change for SARC, as I have decided to step down as President & CEO. I have been privileged to be a part of SARC from … Read more
February 28, 2019 RARE DISEASE DAY 2019 Rare Disease Day 2019 was marked on February 28 around the world and at the NIH with a special day filled with opportunities to meet wonderful people committed to making … Read more
January 18, 2019 LILLY REPORTS RESULTS OF PHASE 3 SOFT TISSUE SARCOMA Today, Eli Lilly reported that the results of their Phase 3 study of olaratumab (LARTRUVO®) in combination with doxorubicin versus doxorubicin alone in patients with advanced or metastatic soft tissue … Read more
June 28, 2018 SARC Investigator-Initiated Osteosarcoma Study Shows Positive Results of Regorafenib SARC (Sarcoma Alliance for Research Through Collaboration) is pleased to report the positive results of their osteosarcoma trial of regorafenib. The goal of improving progression-free survival for patients receiving regorafenib … Read more
June 1, 2018 2018 CAREER DEVELOPMENT PROGRAM AWARD RECIPIENT ANNOUNCED CONGRATULATIONS ANUSHA KALBASI, MD SARC (Sarcoma Alliance for Research Through Collaboration) is pleased to announce Dr. Anusha Kalbasi as the 2018 SARC Career Development Program Award recipient. At the 2018 … Read more
May 10, 2018 SARC009 PUBLISHED JAMA Oncology Publication of SARC Study of Dasatinib Under the leadership of Dr. Scott Schuetze, Professor at the Rogel Cancer Center, Michigan Medicine, the results of the collaborative trial of … Read more
July 18, 2017 SARC021 MANUSCRIPT HAS BEEN PUBLISHED! Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial The SARC021 manuscript has been published … Read more
June 22, 2017 SARC-SUPPORTED RESEARCH SHOWS PEMBROLIZUMAB A POTENTIALLY VIABLE TREATMENT FOR A SUBSET OF SARCOMAS SARC (Sarcoma Alliance for Research Through Collaboration) is pleased to report promising clinical trial results presented recently at ASCO 2017, the Annual Meeting of sarcoma cancer researchers. Melissa A. Burgess, … Read more